Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study
Acta Dermato-Venereologica · 2024
DOI: 10.2340/actadv.v104.26002 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Dermato-Venereologica, 2024. Verfasst von Brigitte Dréno und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France. brigitte.dreno@atlanmed.fr. Hauptthemen laut MEDLINE: Doxycycline, Acne Vulgaris. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Acne in adult females is triggered mainly by hormones. Doxycycline is a reference treatment in acne. Spironolactone targets the androgen receptor of sebaceous glands and is prescribed off-label for female adult acne. This multicentre, controlled, randomized, double-blind prospective and parallel study assessed the efficacy of spironolactone compared with doxycycline in adult female acne. A total of 133 women with moderate acne were randomized to receive treatment with: (i) doxycycline and benzoyl peroxide for 3 months followed by a 3-month treatment with its placebo and benzoyl peroxide, or (ii) spironolactone and benzoyl peroxide for 6 months. Successfully treated patients continued with benzoyl peroxide or spironolactone alone for a further 6 months. Primary endpoints were treatment success at month 4 and month 6 with the AFAST score. At all visits, the ECLA score, lesion counts, local and systemic safety and quality of life were assessed. Spironolactone performed better at month 4 and showed a statistically significant better treatment success after 6 months than doxycycline (p = 0.007). Spironolactone was 1.37-times and 2.87-times more successful compared with doxycycline at respective time-points. AFAST and ECLA scores, as well as lesion counts always improved more with spironolactone. Patients’ quality of life was better with spironolactone at month 4 and month 6. Spironolactone was very well tolerated. This is the first study to show that, in female adults with moderate acne, treatment with spironolactone is significantly more successful than doxycycline and very well tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France. brigitte.dreno@atlanmed.fr.
- Department of Epidemiology and Biostatistics, CHU Nantes, Nantes, France.
- Department of Dermatology, Poitiers University Hospital, Poitiers, France.
- Department of Dermatology, CHU Tours, INSERM U1253, University of Tours, Tours, France.
- Department of Dermatology, Allergology and Photobiology, CHU A. Michallon, Grenoble, France.
- Department of Dermatology, Le Mans Hospital, Le Mans, France.
Zitieren
APA
Dréno, B., Nguyen, J. M., Hainaut, E., Machet, L., Leccia, M. T., Beneton, N., Claudel, J. P., Célérier, P., Le Moigne, M., Le Naour, S., Vrignaud, F., Poinas, A., Dert, C., Boisrobert, A., Flet, L., Korner, S., & Khammari, A. (2024). Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v104.26002
Vancouver
Dréno B, Nguyen JM, Hainaut E, Machet L, Leccia MT, Beneton N, et al. Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study. Acta Dermato-Venereologica. 2024. doi:10.2340/actadv.v104.26002
BibTeX
@article{Drno2024,
author = {Dréno, Brigitte and Nguyen, Jean-Michel and Hainaut, Ewa and Machet, Laurent and Leccia, Marie-Thérèse and Beneton, Nathalie and Claudel, Jean-Paul and Célérier, Philippe and Le Moigne, Marie and Le Naour, Sarah and Vrignaud, Florence and Poinas, Alexandra and Dert, Cécile and Boisrobert, Aurélie and Flet, Laurent and Korner, Simon and Khammari, Amir},
title = {Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study},
journal = {Acta Dermato-Venereologica},
year = {2024},
doi = {10.2340/actadv.v104.26002}
}
EUVIMED